Screener
Medtronic MDT Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Medtronic’s 10-Q, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:18 PM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-011107
| (in millions) | January 23, 2026 | April 25, 2025 |
|---|---|---|
| Total liabilities | 42,289 | 43,424 |
| Commitments and contingencies (Note 16) | ||
| Shareholders’ equity: | ||
| Ordinary shares— par value $0.0001, 2.6 billion shares authorized, 1,283,366,516 and 1,281,934,628 shares issued and outstanding, respectively | — | — |
| Additional paid-in capital | 21,012 | 20,833 |
| Retained earnings | 32,303 | 31,476 |
| Accumulated other comprehensive loss | (4,330) | (4,284) |
| Total shareholders’ equity | 48,985 | 48,024 |
Item 1. Financial Statements
FAQ
- What is Medtronic's common stock, par value (in dollars per share)?
- Medtronic (MDT) reported common stock, par value (in dollars per share) of $0 in Q4 2025.
- How has Medtronic's common stock, par value (in dollars per share) changed year-over-year?
- Medtronic's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Medtronic's common stock, par value (in dollars per share)?
- Over 4 years (2021 to 2025), Medtronic's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about Medtronic's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude